3,3'-(Ethane-1,2-diylbis(sulfanediyl))dipropanenitrile, 97%, 5g

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 100mg

N,N-Diallyl-4-methylbenzenesulfonamide, 95.0%, 10g

6-Chloro-1H-pyrrolo[3,2-b]pyridin-2(3H)-one, 95.0%, 10g

2,3,4,6-Tetrafluorobenzeneboronic acid, 5g

5-[4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

Ethyl 3-methylidenecyclobutane-1-carboxylate, 97% +(stabilized with MEHQ), 5g

L-3-Cyclohexylalanine, 95.0%, 100g

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 1g

4-methyl-2-morpholin-4-ylpentan-1-amine, 95.0%, 500mg

Pallone a fondo tondo a quattro colli Colli laterali paralleli, 4000 ml, 45/40, 1 Pezzo

4-(Azetidin-3-yl)pyridine dihydrochloride, 95.0%, 1g

6-Nitropyridine-2-carboxylic acid, 95.0%, 1g